- Home
- TLX vs UBSI Comparison
TLX vs UBSI Comparison
Compare TLX & UBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLX
- UBSI
- Stock Information
- Founded
- TLX 2015
- UBSI 1982
- Country
- TLX Australia
- UBSI United States
- Employees
- TLX N/A
- UBSI N/A
- Industry
- TLX Biotechnology: Pharmaceutical Preparations
- UBSI Major Banks
- Sector
- TLX Health Care
- UBSI Finance
- Exchange
- TLX Nasdaq
- UBSI Nasdaq
- Market Cap
- TLX 6.0B
- UBSI 4.9B
- IPO Year
- TLX N/A
- UBSI N/A
- Fundamental
- Price
- TLX $17.30
- UBSI $34.34
- Analyst Decision
- TLX Strong Buy
- UBSI Hold
- Analyst Count
- TLX 1
- UBSI 4
- Target Price
- TLX $22.00
- UBSI $41.38
- AVG Volume (30 Days)
- TLX 33.6K
- UBSI 897.5K
- Earning Date
- TLX 01-01-0001
- UBSI 04-24-2025
- Dividend Yield
- TLX N/A
- UBSI 4.25%
- EPS Growth
- TLX 798.14
- UBSI 1.48
- EPS
- TLX 0.09
- UBSI 2.75
- Revenue
- TLX $484,687,790.00
- UBSI $1,009,610,000.00
- Revenue This Year
- TLX N/A
- UBSI $17.77
- Revenue Next Year
- TLX N/A
- UBSI $6.56
- P/E Ratio
- TLX $195.56
- UBSI $12.74
- Revenue Growth
- TLX 55.85
- UBSI N/A
- 52 Week Low
- TLX $14.01
- UBSI $30.68
- 52 Week High
- TLX $30.36
- UBSI $44.43
- Technical
- Relative Strength Index (RSI)
- TLX N/A
- UBSI 40.90
- Support Level
- TLX N/A
- UBSI $34.33
- Resistance Level
- TLX N/A
- UBSI $35.64
- Average True Range (ATR)
- TLX 0.00
- UBSI 0.65
- MACD
- TLX 0.00
- UBSI 0.13
- Stochastic Oscillator
- TLX 0.00
- UBSI 42.21
About TLX Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
About UBSI United Bankshares Inc.
United Bankshares Inc is a financial holding company that provides banking services. The company operates in one segment: Community banking, which accepts deposits, makes loans (for personal, credit card, commercial, and construction uses), provides brokerage services, safe deposit boxes, and related services.